The current political clash between the US and China will stall US digital health companies from laying down roots in China in the near term.
Digital health companies have already landed in the crosshairs of the US-China dispute. The Trump administrationMassachusetts-based PatientsLikeMe to separate itself from Chinese digital health company iCarbonX — which laid claim to most of its stake — in April. This could be a warning sign for US startups turning their sights to China for capital and tie-ups.
The threat of government backlash could deter smaller players from moving into China's market, and it also might make US companies an unappealing choice for Chinese companies looking for partners: Chinese funding for US businesses has plummetedSo, as long as the strife between the US and China prevails, we don't think we'll see an upsurge of US companies flocking to China. If tensions cool in the coming years, though, the region could present a huge opportunity for US companies.
, Business Insider Intelligence's expert product suite keeping you up-to-date on the people, technologies, trends, and companies shaping the future of healthcare, delivered to your inbox 6x a week. >>pass to Business Insider Intelligence and gain immediate access to Digital Health Pro, plus more than 250 other expertly researched reports.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »